| domain | cslbehring.com.sa |
| summary | CSL is a biopharmaceutical company focused on developing and commercializing therapies for diseases affecting the cardiovascular system. Their primary product, Victoza (exenatide), is a GLP-1 receptor agonist used to treat type 2 diabetes. They also have a pipeline of therapies targeting other cardiovascular conditions like heart failure and pulmonary hypertension. CSL’s business is broadly divided into two segments: CSL Plasma and CSL Behring. CSL Plasma produces plasma-derived therapies for hemophilia and other bleeding disorders. CSL Behring manufactures coagulation and plasma therapies for a range of conditions. |
| title | CSL Behring Saudi Arabia |
| description | CSL Behring Saudi Arabia |
| keywords | rights, english |
| upstreams |
|
| downstreams |
|
| nslookup | A 12.3.33.221 |
| created | 2025-11-09 |
| updated | 2026-01-01 |
| summarized | 2026-01-30 |
|
|